Result of AGM

RNS Number : 7212Q
Galantas Gold Corporation
30 June 2022
 

 

 


GALANTAS GOLD REPORTS AGM RESULTS

 

 

June 30, 2022, TORONTO, CANADA - Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) ("Galantas" or the "Company") is pleased to report the results of its Annual and Special Meeting held on June 27, 2022.

 

All resolutions were passed by shareholders.

Shareholders voted in favour of the election of all director nominees for the ensuing year: Mario Stifano, James B. Clancy, Roisin Magee, David Cather, and Brent Omland.

Shareholders also voted in favour of (i) appointing Clearhouse LLP, Chartered Professional Accountants as the auditors of the Company for the ensuing year and authorizing the Board of Directors to fix their remuneration; and (ii) ratifying and confirming the "rolling" stock option plan of the Company as more particularly set out in its Management Information Circular.

A total of 49,405,389 Galantas common shares were voted, representing 59.5% of total shares issued and outstanding as at the record date of the meeting.

About Galantas Gold Corporation

 

Galantas Gold Corporation is a Canadian public company that trades on the TSX-Venture Exchange and the London Stock Exchange AIM market, both under the symbol GAL. It also trades on the OTCQX Exchange under the symbol GALKF. The Company's strategy is to create shareholder value by operating and expanding Northern Ireland's first gold mine.

 

Enquiries

 

Galantas Gold Corporation

Mario Stifano: Chief Executive Officer

Email: info@galantas.com

Website: www.galantas.com

Telephone: +44(0)28 8224 1100

 

Grant Thornton UK LLP (AIM Nomad)

Philip Secrett, Harrison Clarke, George Grainger, Samuel Littler

Telephone: +44(0)20 7383 5100

 

Panmure Gordon & Co (AIM Broker & Corporate Adviser)

Hugh Rich, John Prior

Telephone: +44(0)20 7886 2500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUKAWRUVUNUAR
UK 100

Latest directors dealings